$0.0330
-0.00700-17.50%
At close: -
$0.0405
0.0075022.73%
After Hours: 8:00 AM EDT
Comments
Loading...
Syros Pharmaceuticals Insider Trading Activity | OTC:SYRS | Benzinga
Track the latest Syros Pharmaceuticals insider trading activity. Stay informed on recent buys, sells, and market impact for Syros Pharmaceuticals stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Syros Pharmaceuticals Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
There has been no Insider buying or selling in the last 90 days.
Ownership Statistics for Syros Pharmaceuticals Inc
Shares Outstanding
26.810M
Insider Shares Owned
460.162K
Insider Percentage Owned
1.71%
Institutional Shares Held
1.052M
Institutional Percentage Held
3.92%
| Dec 04, 2024 | Nancy Simonian | — | -37.07K | $0.27 | -$10.02K | SELL | -90.26% | 4.00K | Dec 02 | View |
| Nov 27, 2024 | Nancy Simonian | — | -134.71K | $0.27 | -$35.74K | SELL | -76.64% | 41.07K | Nov 25 | View |
| Nov 20, 2024 | Kristin Stephens | CHIEF DEVELOPMENT OFFICER | -36.13K | $0.22 | -$7.95K | SELL | -100.00% | 0.00 | Nov 18 | View |
| Nov 20, 2024 | David Roth | CHIEF MEDICAL OFFICER | -12.10K | $0.20 | -$2.38K | SELL | -100.00% | 0.00 | Nov 18 | View |
| Nov 20, 2024 | Gerald Quirk | CHIEF LEGAL & COMPLIANCE OFFIC | -46.66K | $0.22 | -$10.32K | SELL | -100.00% | 0.00 | Nov 19 | View |
| Nov 20, 2024 | Conley Chee | PRESIDENT & CEO | -134.80K | $0.20 | -$26.93K | SELL | -100.00% | 0.00 | Nov 18 | View |
| Nov 20, 2024 | Jason Haas | CHIEF FINANCIAL OFFICER | -137.80K | $0.21 | -$28.98K | SELL | -100.00% | 0.00 | Nov 18 | View |
| Sep 12, 2024 | Conley Chee | PRESIDENT & CEO | 100.00K | $1.61 | $160.68K | BUY | 444.37% | 122.50K | Sep 10 - Sep 11 | View |
| Sep 12, 2024 | Jason Haas | CHIEF FINANCIAL OFFICER | 100.00K | $1.61 | $161.24K | BUY | 407.30% | 124.55K | Sep 10 - Sep 12 | View |
| Jul 02, 2024 | Richard Young | — | -34.84K | $5.12 | -$178.37K | SELL | -81.32% | 8.00K | Jun 28 | View |
| Apr 05, 2024 | David Roth | CHIEF MEDICAL OFFICER | -10.45K | $4.95 | -$51.73K | SELL | -100.00% | 0.00 | Apr 03 | View |
| Apr 02, 2024 | David Roth | CHIEF MEDICAL OFFICER | 10.45K | $5.12 | -$24.97K | SELL-OPTIONS | ∞ | 10.45K | Mar 31 - Apr 02 | View |
| Dec 26, 2023 | Srinivas Akkaraju | DIRECTOR | 904.98K | $4.42 | $4.00M | BUY | 102.36% | 1.79M | Dec 21 | View |
| Dec 14, 2023 | David Roth | CHIEF MEDICAL OFFICER | -6.29K | $4.95 | -$31.12K | SELL | -100.00% | 0.00 | Dec 12 | View |
| Dec 08, 2023 | David Roth | CHIEF MEDICAL OFFICER | -6.29K | $3.95 | -$24.83K | SELL | -50.00% | 6.29K | Dec 06 | View |
| Aug 02, 2023 | David Roth | CHIEF MEDICAL OFFICER | -7.35K | $3.95 | -$29.02K | SELL | -100.00% | 0.00 | Jul 31 | View |
| Jul 18, 2023 | Eric Olson | CHIEF SCIENTIFIC OFFICER | -689.00 | $3.50 | -$2.41K | SELL | -9.37% | 6.66K | Jul 17 | View |
| Oct 03, 2022 | TIMOTHY TYSON | DIRECTOR | 16.93K | $6.26 | $105.96K | BUY | 211.65% | 24.93K | Sep 29 - Sep 30 | View |
| Jan 06, 2022 | Eric Olson | CHIEF SCIENTIFIC OFFICER | -2.21K | $3.47 | -$7.65K | SELL | -100.00% | 0.00 | Jan 05 | View |
| Jul 01, 2021 | Eric R Olson | CHIEF SCIENTIFIC OFFICER | -1.16K | $5.55 | -$6.46K | SELL | -100.00% | 0.00 | Jul 01 | View |
| Mar 17, 2021 | Eric Olson | CHIEF SCIENTIFIC OFFICER | 0.00 | $5.24 | -$30.71K | SELL-OPTIONS | 0.00% | 0.00 | Mar 15 | View |
| Feb 18, 2021 | Richard Young | DIRECTOR | -3.75K | $12.05 | -$45.19K | SELL | -1.15% | 321.71K | Feb 16 | View |
| Feb 10, 2021 | Richard Young | DIRECTOR | -3.75K | $13.04 | -$48.90K | SELL | -1.14% | 325.46K | Feb 08 | View |
| Nov 18, 2020 | Richard Young | — | -5.99K | $8.77 | -$52.56K | SELL | -1.74% | 339.21K | Nov 16 - Nov 17 | View |
| Oct 19, 2020 | Richard Young | — | -5.67K | $8.75 | -$49.64K | SELL | -1.66% | 335.20K | Oct 19 | View |
| Oct 16, 2020 | Richard Young | — | -317.00 | $8.75 | -$2.77K | SELL | -0.09% | 340.87K | Oct 15 | View |
| Sep 16, 2020 | Richard Young | — | -5.99K | $10.39 | -$62.24K | SELL | -1.73% | 341.19K | Sep 15 | View |
| Aug 19, 2020 | Eric Olson | — | 0.00 | $7.00 | -$188.84K | OPTION EXERCISE | 0.00% | 0.00 | Aug 17 - Aug 18 | View |
| Aug 19, 2020 | Richard Young | — | -5.99K | $12.59 | -$75.41K | SELL | -1.70% | 347.18K | Aug 17 | View |
| Aug 19, 2020 | Srinivas Akkaraju | — | -159.33K | $13.10 | -$2.09M | SELL | -11.11% | 1.27M | Aug 17 - Aug 18 | View |
| Jul 17, 2020 | Richard Young | — | -5.99K | $11.85 | -$70.98K | SELL | -1.67% | 353.17K | Jul 15 | View |
| Jul 07, 2020 | Eric R Olson | — | -1.75K | $11.72 | -$20.54K | SELL | -100.00% | 0.00 | Jul 07 | View |
| Jul 06, 2020 | Srinivas Akkaraju | — | -4.63K | $11.01 | -$50.97K | SELL | -0.32% | 1.43M | Jul 01 | View |
| Jun 25, 2020 | Srinivas Akkaraju | — | -154.70K | $11.11 | -$1.72M | SELL | -9.71% | 1.44M | Jun 23 - Jun 25 | View |
| Jun 16, 2020 | Richard Young | — | -5.99K | $8.75 | -$52.41K | SELL | -1.64% | 359.16K | Jun 15 | View |
| May 15, 2020 | Richard Young | — | -5.99K | $9.22 | -$55.24K | SELL | -1.61% | 365.15K | May 15 | View |
| May 13, 2020 | Mark Alles | — | 10.00K | $8.86 | $88.59K | PURCHASE | ∞ | 10.00K | May 13 | View |
| Apr 17, 2020 | Richard Young | — | -23.96K | $8.75 | -$209.65K | SELL | -6.06% | 371.14K | Apr 15 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.